Triglyceride and Lp(a) concentrations in hyperapobetalipoproteinemia [2]

Clinica Chimica Acta

Volumn 294, Issue 1-2, 2000, Pages 199-203

  Sorell, L ^a,b   Simon, R ^b  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b Institute of Angiology and Vascular Surgery   (Cuba)

Author keywords

Hyperapobetalipoproteinemia; Lp(a); Triglycerides

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LETTER; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ANGINA PECTORIS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEIN(A); MIDDLE AGED; MYOCARDIAL INFARCTION; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0034014880     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00262-4     Document Type: Letter

References (15)

1. R. Tracy W. Newman W. Wattigney G. Berenson Risk factors and atherosclerosis in youth. Autopsy findings of the Bogalusa Heart Study Am. J. Med. Sci 310 1 1995 S37 S41
2. K. Pyoralla G. De Baker I. Graham P. Poole-Wilson D. Wood Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Hypertension Eur Heart J 15 1994 1300 1331
3. R. Deckelbaum N. Galeano Small dense low density lipoprotein: Formation and potential mechanism for atherogenecity Israel J Med Sci 32 1996 464 468
4. S. Djurovic K. Berg Epidemiology of Lp(a) lipoprotein: its role in atherosclerosis/thrombotic disease Clin Genet 52 1997 281 292
5. G.H. Dahlen H. Stenlund Lp(a) lipoprotein is a major risk factor for cardiovascular disease:pathogenic mechanisms and clinical significance Clin Genet 52 1997 272 280
6. A.M. Gotto Triglyceride. The forgotten risk factor Circulation 97 1998 1027 1028
7. J. Jeppesen H. Ole Hein P. Suadicani F. Gyntelberg Triglyceride concentrations and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study Circulation 97 1998 1029 1036
8. L. Sorell G. Rojas M. Rodrı́guez C. Ramos L. Torres M.B. Torres A sandwich Elisa based on monoclonal antibodies for lipoprotein(a) measurement Clin Chim Acta 236 1995 59 70
9. L. Sorell J. López M. Cabrera Quantitation of apolipoprotein B with monoclonal antibodies as indicator of atherogenic risk Interf Biotechnol 6 1989 258 264
10. L. Sorell M. Pérez M. Rodrı́guez Monoclonal antibodies for Apo A1 measurement Biotec Applic 7 1990 58 65
11. W.T. Friedewald R.I. Levy D.S. Fredickson Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
12. A. Clauss Gerrinnuge physiologische schnellmethode sur bestimmung des fibrinogens Acta Haematol 17 1957 237 246
13. S. Haffner L. Mykkanen D. Robbins A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects Diabetologia 38 1995 1328 1336
14. B. Griffin D. Freeman G. Tait Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk Atherosclerosis 106 1994 241 253
15. W. Capelli A. Zambon M. Austin J. Brunzell J. Hokanson Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B Arterioscler Thromb Vasc Biol 16 1996 1040 1046